Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
BAN-ORL-24
A2A or A2B ARs
whereas Infliximab (10 ng/mL) reverses TNF-α actions by significantly improving glucose incorporation in 3T3L1 adipocytes
which is known to exhibit antivascular effects through selective disruption of the tubulin cytoskeleton of endothelial cells
SalB treatment also reduced the number of activated microglia and astrocytes that are observed during the inflammatory reaction after the administration of the Aβ25-35 peptide
MRK-016 IA BAN-ORL-24MRK 016 is a selective, orally bioavailable inverse agonist of GABAA 5 receptor, with an EC50 of 3 nM for GABAA 5, and Kis of 0. 83, 0. 85, 0. 77 and 1. 4 nM for human GABAA 132, GABAA 232, GABAA 332, and GABAA 532, respectively; MRK 016 also readily penetrates the CNS. Product information CAS Number: 342652 67 9 Molecular Weight: 368. 39 Formula: C17H20N8O2 Chemical Name: 5 ({[3 tert butyl 7 (5 methyl 1,2 oxazol 3 yl)pyrazolo[1,5 d][1,2,4]triazin 2
US$ 164.50
US$ 42.00
US$ 20.00
US$ 17.00
US$ 38.00